Atapattu-Weerasinghe v Accident Compensation Corporation

Link copied
Case Copied 23 min read

IN THE HIGH COURT OF NEW ZEALAND WELLINGTON REGISTRY

CIV-2016-485-210 [2017] NZHC 142

BETWEEN

SHANE ATAPATTU-WEERASINGHE

Applicant

AND

ACCIDENT COMPENSATION CORPORATION

Respondent

Hearing: 25 October 2016

Counsel:

H G De Groot for Applicant
C J Hlavac for Respondent

Judgment:

13 February 2017

JUDGMENT OF WILLIAMS J

[1]      The applicant seeks special leave to appeal the decision of the District Court declining him coverage under the Accident Compensation Act 2001.1     This application follows the decision of Judge Harrison declining him leave to appeal.2

[2]      Special leave may only be granted to bring a second appeal on a question of law.3    Leave to bring a second appeal in this fashion is not lightly granted partly because  leave  has  already been  declined  once  in  the  District  Court,  and  partly because the role of this Court on a second appeal is not broadly corrective.  Rather, it is focused on issues of principle and matters of importance beyond the interests of the parties in dispute.

[3]      White J in Cullen v ACC put the position succinctly as follows:4

1      Accident Compensation Corporation v Atapattu-Weerasinghe [2015] NZACC 255 [coverage judgment].

2      Atapattu-Weerasinghe v Accident Compensation Corporation [2016] NZACC 73 [leave judgment].

3      Section 162 of the Accident Compensation Act 2001.

4      Cullen v Accident Compensation Corporation [2014] NZCA 94 at [5].

ATAPATTU-WEERASINGHE v ACCIDENT COMPENSATION CORPORATION [2017] NZHC 142 [13 February 2017]

The Court will exercise this power if satisfied that there is a serious question of law capable of bona fide and serious argument in a case involving some interest, public or private of sufficient importance to outweigh the cost and delay of a further appeal.   Other relevant considerations include the desirability of finality of litigation and the overall interests of justice.  The primary focus is on whether the question of law is worthy of consideration.

[4]      I will approach this application with that guidance in mind.

Factual background

[5]      The applicant worked in a bakery at a supermarket.  In May 2009, a bag of flour fell on his left wrist injuring it.  He was given a steroid injection to treat it.  On

12 September of that year he suffered a rotator cuff injury to his left shoulder while working with one of the machines at the site.  Because of ongoing pain, the applicant was prescribed diclofenac, a non-steroidal anti-inflammatory drug (NSAID).   The left shoulder became infected at the site of the injury.

[6]      On 24 September 2009, the applicant was admitted to Waikato Hospital.  He was diagnosed with Methicillian-Resistant Staphylococcus Aureus (MRSA) septicaemia and multi-organ failure.  He had an abscess in his left shoulder and was also diagnosed with necrotising fasciitis in relation to his right wrist and forearm.

[7]      Necrotising  fasciitis  is  a  rare  and  life  threatening  disease  with  a  high mortality rate.  It is a disease that results in the death of the body’s soft tissue.  It was accepted that in the applicant’s case, this was caused by the presence of MRSA bacteria  in  his  bloodstream,  but  it  is  not  possible  to…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Atapattu-Weerasinghe v Accident Compensation Corporation and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2017] NZHC 142
Decision Date

CaseChat Overview and Summary

In this case, the applicant, Shane Atapattu-Weerasinghe, seeks special leave to appeal the District Court's decision declining him coverage under the Accident Compensation Act 2001. The applicant's injuries stem from a workplace incident in 2009, and subsequent infection by Methicillin-Resistant Staphylococcus Aureus (MRSA). The applicant's case involves complex issues of causation, particularly in relation to the role of NSAIDs treatment in the progression of the infection. The court was asked to decide several legal questions, including whether the Daubert principles should be applied in assessing scientific evidence in New Zealand, and whether the District Court erred in not addressing a claim under section 20(2)(g) of the Act. The court granted special leave to appeal on two questions, focusing on the District Court's interpretation and application of the causation test in relation to the treatment injury claim, and whether the District Court erred in not ruling on the validity of the section 20(2)(g) claim.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.